Literature DB >> 31981224

Coronavirus infections and immune responses.

Geng Li1,2, Yaohua Fan3, Yanni Lai3, Tiantian Han3, Zonghui Li2, Peiwen Zhou1, Pan Pan2, Wenbiao Wang1, Dingwen Hu4, Xiaohong Liu5, Qiwei Zhang1,6, Jianguo Wu1,4.   

Abstract

Coronaviruses (CoVs) are by far the largest group of known positive-sense RNA viruses having an extensive range of natural hosts. In the past few decades, newly evolved Coronaviruses have posed a global threat to public health. The immune response is essential to control and eliminate CoV infections, however, maladjusted immune responses may result in immunopathology and impaired pulmonary gas exchange. Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs. In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clinical treatment.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  chemokine; coronavirus; cytokines; inflammation; interferon

Year:  2020        PMID: 31981224     DOI: 10.1002/jmv.25685

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  538 in total

Review 1.  Hematopoietic stem and progenitor cells directly participate in host immune response.

Authors:  Olusola Jumoke Daramola; Stephen Osasan; Hebah Ali; Perpetua Emeagi
Journal:  Am J Stem Cells       Date:  2021-06-15

Review 2.  Dermatology practice in the times of the COVID-19 pandemic.

Authors:  Deepak Vashisht; Shekhar Neema; Ruby Venugopalan; Vikas Pathania; Sunmeet Sandhu; Biju Vasudevan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021-04-23       Impact factor: 2.545

3.  Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology.

Authors:  Ismail Pasha; Rohini S Kavalapure; Sharad Chand; Shailendra Gurav; Pukar Khanal; Taaza Duyu; B M Patil; Yadu Nandan Dey
Journal:  3 Biotech       Date:  2021-02-08       Impact factor: 2.406

Review 4.  Coronavirus Disease 2019-COVID-19.

Authors:  Kuldeep Dhama; Sharun Khan; Ruchi Tiwari; Shubhankar Sircar; Sudipta Bhat; Yashpal Singh Malik; Karam Pal Singh; Wanpen Chaicumpa; D Katterine Bonilla-Aldana; Alfonso J Rodriguez-Morales
Journal:  Clin Microbiol Rev       Date:  2020-06-24       Impact factor: 26.132

5.  A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.

Authors:  Yingping Wu; Tiejun Zhao; Riqiang Deng; Xiaoping Xia; Bin Li; Xunzhang Wang
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

6.  Data analytics to evaluate the impact of infectious disease on economy: Case study of COVID-19 pandemic.

Authors:  Meleik Hyman; Calvin Mark; Ahmed Imteaj; Hamed Ghiaie; Shabnam Rezapour; Arif M Sadri; M Hadi Amini
Journal:  Patterns (N Y)       Date:  2021-07-27

7.  2019-nCoV: Polite with children!

Authors:  Désirée Caselli; Maurizio Aricò
Journal:  Pediatr Rep       Date:  2020-02-11

Review 8.  A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.

Authors:  Krishna Sriram; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-05-22       Impact factor: 8.739

9.  Neurosurgery in an infant with COVID-19.

Authors:  Giorgio Carrabba; Leonardo Tariciotti; Sophie Guez; Edoardo Calderini; Marco Locatelli
Journal:  Lancet       Date:  2020-04-22       Impact factor: 79.321

10.  Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity.

Authors:  Shuai Wang; Tong Dai; Ziran Qin; Ting Pan; Feng Chu; Lingfeng Lou; Long Zhang; Bing Yang; Huizhe Huang; Huasong Lu; Fangfang Zhou
Journal:  Nat Cell Biol       Date:  2021-07-08       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.